Discussing overall prognosis with the very elderly.

Division of Geriatrics, Department of Medicine, University of California, San Francisco, USA.
New England Journal of Medicine (Impact Factor: 54.42). 12/2011; 365(23):2149-51. DOI: 10.1056/NEJMp1109990
Source: PubMed

ABSTRACT Though life expectancy inexorably decreases with advancing age, we tend to avoid discussing overall prognosis with elderly patients who have no dominant terminal illness. But we may thereby undercut patients' ability to make informed choices about their future.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Pulmonary tumour thrombotic microangiopathy (PTTM) is a rare complication of metastatic cancer with a distinct histological appearance which presents with dyspnoea and pulmonary arterial hypertension and leads to death in hours to days. It is a challenging diagnosis to make ante mortem, in part due to the rapid clinical decline. Herein, we report a case of a young woman initially felt to have pulmonary sarcoidosis but who then died eight days later from what was found at post mortem to be PTTM. Case presentation A 41 year old Caucasian woman presented with progressive dyspnoea. Computed tomography of her thorax showed diffuse tiny centrilobular nodules in a tree-in-bud appearance along with small volume mediastinal lymphadenopathy. A presumptive diagnosis of pulmonary sarcoidosis was made; bronchoscopy with transbronchial lung biopsy was arranged to confirm the diagnosis. However, she rapidly deteriorated and died eight days later. Post mortem examination revealed metastatic poorly differentiated gastric adenocarcinoma with PTTM being the final cause of death. Conclusion This case demonstrates the diagnostic difficulties in such a rare and rapidly fatal oncological complication; a greater awareness amongst clinicians may help make a positive diagnosis in the short window of time available. Little is known about its pathogenesis, and even less about optimal management strategies. We review the literature to demonstrate the clinical characteristics that might provide clues towards an ante mortem diagnosis, and highlight how imatinib may provide the key to treating PTTM. Electronic supplementary material The online version of this article (doi:10.1186/s12885-015-1467-7) contains supplementary material, which is available to authorized users.
    BMC Cancer 06/2015; 15(1). DOI:10.1186/s12885-015-1467-7 · 3.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hintergrund und Problematik Notrufe an den Rettungsdienst erweisen sich aus Sicht der Rettungskräfte bei Eintreffen oft als nicht notwendig. Allerdings steht hinter dem Notruf ein komplexer Entscheidungsprozess, in dem die subjektive Interpretation der Situation durch den Patienten, von Angehörigen oder zufälligen Augezeugen eine entscheidende Rolle spielen. Für bestimmte, v. a. die sozial schwächsten Bevölkerungsgruppen ist der Rettungsdienst oft der einzige Anker, der schnelle Hilfe in schwierigen Situationen bietet. Die Einsatzleitstelle verfügt nur über sehr begrenzte Möglichkeiten, die Sinnhaftigkeit eines Notrufs zu beurteilen. Abfrageschemata könne den Disponenten unterstützen, ihm aber die Entscheidung nicht abnehmen. Eigentlich sollte man von medizinisch geleiteten Institutionen am ehesten erwarten, dass Notrufe gezielt erfolgen. Es ist allerdings festzustellen, dass aus Alten- und Pflegeheimen und aus der Hauskrankenpflege häufig unnötige Notrufe erfolgen. Hier mangelt es ebenso an klaren Anweisungen durch die betreuenden Ärzte wie auch bei der häusliche Pflege von Schwerkranken und Sterbenden durch Angehörige. Schlussfolgerung Es ist notwendig, dass die betreuenden Ärzte im Vorfeld Gespräche mit Pflegenden, Angehörigen und Patienten führen, nicht nur um unnötige Rettungsdienstalarme zu vermeiden, sondern auch um unnötige oder gar sinnlose Maßnahmen und Krankenhauseinweisungen – schlimmstenfalls sogar gegen den Willen des Patienten – zu verhindern.
    Notfall 12/2012; 15(8):661-666. DOI:10.1007/s10049-011-1542-9 · 0.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Elderly patients with multimorbidity who are treated according to guidelines use a large number of drugs. This number of drugs increases the risk of adverse drug events (ADEs). Stopping medication may relieve these effects, and thereby improve the patient's wellbeing. To facilitate management of polypharmacy expert-driven instruments have been developed, sofar with little effect on the patient's quality of life. Recently, much attention has been paid to shared decision-making in general practice, mainly focusing on patient preferences. This study explores how experienced GPs feel about deprescribing medication in older patients with multimorbidity and to what extent they involve patients in these decisions. Focusgroups of GPs were used to develop a conceptual framework for understanding and categorizing the GP's view on the subject. Audiotapes were transcribed verbatim and studied by the first and second author. They selected independently relevant textfragments. In a next step they labeled these fragments and sorted them. From these labelled and sorted fragments central themes were extracted. GPs discern symptomatic medication and preventive medication; deprescribing the latter category is seen as more difficult by the GPs due to lack of benefit/risk information for these patients.Factors influencing GPs'deprescribing were beliefs concerning patients (patients have no problem with polypharmacy; patients may interpret a proposal to stop preventive medication as a sign of having been given up on; and confronting the patient with a discussion of life expectancy vs quality of life is 'not done'), guidelines for treatment (GPs feel compelled to prescribe by the present guidelines) and organization of healthcare (collaboration with prescribing medical specialists and dispensing pharmacists. The GPs' beliefs concerning elderly patients are a barrier to explore patient preferences when reviewing preventive medication. GPs would welcome decision support when dealing with several guidelines for one patient. Explicit rules for collaborating with medical specialists in this field are required. Training in shared decision making could help GPs to elicit patient preferences.
    BMC Family Practice 06/2012; 13:56. DOI:10.1186/1471-2296-13-56 · 1.74 Impact Factor